Investor Overview

VYNE Therapeutics™ is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

1.92

Mar. 18, 2024 16:00:00
  • Change -0.09 (-4.4776%)
  • Volume 74,132
  • Today's Open 2.01
  • Previous Close 2.01
  • Today's High 2.0243
  • Today's Low 1.92
  • 52 Week High 8.73
  • 52 Week Low 1.67